• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pusey Appointed President, CEO of Omnicare Clinical Research

Pusey Appointed President, CEO of Omnicare Clinical Research

October 20, 2009
CenterWatch Staff

Omnicare appointed James Pusey as president and CEO of Omnicare Clinical Research. In his new position, Pusey will be responsible for Omnicare’s contract research organization (CRO) operations worldwide.

Pusey succeeds Dr. Dale B. Evans, who has resigned to pursue other opportunities. 

“Dr. Pusey has a wealth of experience in all aspects of the CRO business—from research and drug development to operations, sales and customer relationships—and we believe he will add significant value to our organization,” said Joel Gemunder, Omnicare’s president and CEO.

“Under Dr. Pusey’s leadership, we look forward to leveraging the organization’s assets to further strengthen Omnicare’s presence in the clinical research business, and to develop new growth opportunities. “Omnicare’s CRO operations, including Omnicare Clinical Research, headquartered in King of Prussia, Penn., and Clinimetrics Research Associates, based in San Jose, Calif., provide comprehensive product development and research services.

Pusey added, “Omnicare has a CRO platform that not only has a full complement of drug development and commercialization services across a broad global footprint but also has unique opportunities in the biotech arena and in geriatric research. I am encouraged by the long-term outlook for the CRO industry and by the prospects inherent in Omnicare’s CRO business.”

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing